Bethesda, MD, United States of America

Carl Merril

This inventor holds 2 USPTO granted patents and 7 published patent applications and 2 EPO patents. Top assignee: Adaptive Phage Therapeutics, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carl Merril. Retrieved from https://idiyas.com/inventor/carl-merril

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.7

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Carl Merril

Introduction

Carl Merril is an accomplished inventor based in Bethesda, MD, known for his significant contributions to the field of phage therapy. With a total of two patents to his name, Merril has focused on developing methods and systems that enhance the therapeutic use of bacteriophages.

Latest Patents

Merril's latest patents include a "Method for purification of bacteriophage particles" and a "Phage dispensing system." The purification method outlines a universal approach to recovering viable phage from crude preparations, ensuring low endotoxin levels and high phage titers suitable for therapeutic applications. The phage dispensing system integrates a user interface, a computing system, and a laboratory to facilitate the identification and dispensing of phage treatments for patients.

Career Highlights

Merril's work at Adaptive Phage Therapeutics, Inc. has positioned him at the forefront of phage therapy innovation. His research aims to provide effective treatments for bacterial infections, leveraging the unique properties of bacteriophages.

Collaborations

Merril collaborates with notable colleagues such as Greg Merril and Joseph Robert Fackler, contributing to a dynamic team focused on advancing phage therapy.

Conclusion

Carl Merril's innovative work in bacteriophage research and therapy exemplifies the potential of phage technology in modern medicine. His patents and contributions continue to pave the way for new therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…